Search results
Kendra J Grubb
Job title: Surgical Director
Author
Edwards Lifesciences
Supplier
Author(s):
Raj Makkar
Added:
5 months ago
In this insightful interview, investigator, Prof Raj R Makkar(Cedars-Sinai Heart Institute, US) joins us to discuss the outcomes of repeat transcatheter aortic valve replacement with balloon-expandable valves.
Prof Makkar and his team used the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry to address a series of questions regarding the safety…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
5 months ago
What are the top late-breaking trials from #TCT2023?
TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference.
Dive into this practical and engaging discussion and learn more about the…
View more
Author(s):
Susheel Kodali
Added:
2 years ago
In this interview, Dr Susheel Kodali (Columbia University Medical Center, New York, US) discusses the 30-day results of the TRISCEND trial. He details the key findings of the study so far, and the next steps to be taken.Thismulti-centre, prospective, single-arm study evaluates the safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System
Questions:
1.What is the TRISCEND…
View more
Author(s):
Raj Makkar
Added:
2 years ago
In this interview, Dr Raj Makkar (Cedars-Sinai Medical Center, Los Angeles, CA, US) discusses the Transcatheter Aortic Valve Replacement for bicuspid aortic stenosis in a patient population with low risk for surgery.
Questions:
What is the rationale for this study?
Describe the design, patient population and endpoints?
What are the key findings and what conclusions can be made?
Which patients…
View more
Author(s):
Susheel Kodali
Added:
2 years ago
Dr Susheel Kodali (Columbia University Medical Center, New York, NY, US) discusses the six-month outcomes of the TRISCEND study.Originally presented at TCT 2021, this is a randomized multicenter controlled trial aiming to evaluate the safety and effectiveness of the EVOQUE tricuspid valve replacement system. At 6 months, the results suggest positive outcomes, with a reduction in tricuspid…
View more
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
3 days ago
What’s hot at ACC.24?Join interventional experts, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, Rotterdam, NL) to learn more about this year’s key late-breaking and featured science trials that have the potential to shape practice and research.This preview episode of View from the Thoraxcenter offers a critical analysis of the most anticipated trials of ACC.24,…
View more
Vinayak Bapat
Job title: Surgical Director, Mitral and Tricuspid Therapies
Author
Author(s):
John Forrest
Added:
1 year ago
ACC.23/WCC - We are joined onsite by Dr John Forrest (Yale Valve Clinic, US) in this short video, who outlines the three-year outcomes of the Evolut Low-Risk Trial(Medtronic Cardiovascular) (NCT02701283).
This study aimed to compare transcatheter aortic valve replacement (TAVR) using Medtronic's TAVR valve with surgical aortic valve replacement (SAVR) in over 2000 patients with aortic stenosis…
View more